Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2022-12-02

Clinical Trial Update: Effects of Phenoximethylpenicillin, Amoxicillin and Amoxicillin-clavulanic Acid on the Gut Microbiota [Phase 4]

View source ↗

Summary

Phase 4 trial examining how phenoximethylpenicillin, amoxicillin, and amoxicillin-clavulanic acid affect the gut microbiota.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • AMOXICILLIN (AMOXICILLIN)
  • Amoxicillin/clavulanic acid (amoxicillin/clavulanic acid)
  • phenoximethylpenicillin (phenoximethylpenicillin)

Snippet

Sponsor: Uppsala University | Conditions: Infectious Disease | Phase 4 | Status: COMPLETED